Hyperaldosteronism: Difference between revisions
No edit summary |
No edit summary |
||
Line 20: | Line 20: | ||
{| class="wikitable" | {| class="wikitable" | ||
! rowspan="2" | | |||
! rowspan="2" |Cause | |||
! colspan="4" |Laboratory | |||
|- | |||
!Renin activity | |||
!Aldosterone levels | |||
!urinary free cortisone | |||
! | ! | ||
|- | |||
|[[Renin-producing tumors]] | |||
| | |||
|↑ | |||
|↑ | |||
|↓ | |||
| | |||
|- | |||
|[[Apparent mineralocorticoid excess]] | |||
| | |||
|↓ | |||
|↓ | |||
|↓↓ | |||
| | |||
|- | |||
|[[Licorice]] ingestion | |||
| | |||
|↓ | |||
|↓ | |||
|Moderate ↑ | |||
| | |||
|- | |||
|Ectopic ACTH production | |||
| | |||
|↓ | |||
|↑ | |||
|Markedly ↑↑ | |||
| | |||
|- | |||
|Primary hyperaldosteronism | |||
| | |||
|↓ | |||
|↑ | |||
|↓ | |||
| | |||
|- | |||
|Familial hyperaldosteronism | |||
| | |||
|↓ | |||
|↑ | |||
|↓ | |||
| | |||
|- | |||
|Cushing syndrome | |||
| | |||
|↓ | |||
|↑ | |||
|Markedly ↑↑ | |||
| | |||
|- | |||
|Renal artery stenosis | |||
| | |||
|↑ | |||
|↑ | |||
|↓ | |||
| | |||
|- | |||
|[[Liddle's syndrome]] | |||
| | |||
|↓ | |||
|↓ | |||
|↓ | |||
| | |||
|- | |||
|[[Diuretic]] use | |||
| | |||
|Nl | |||
| | |||
|↓ | |||
| | |||
|- | |||
|[[17 alpha-hydroxylase deficiency|17 alpha hydroxylase deficiency]] | |||
| | |||
|↓ | |||
|↓ | |||
|↓ | |||
| | |||
|- | |||
|[[11β-hydroxylase deficiency|11 beta hydroxylase deficiency]] | |||
| | |||
|↓ | |||
|↓ | |||
|↓ | |||
| | |||
|- | |||
|Coarctation of aorta | |||
| | |||
| | |||
| | |||
|↓ | |||
| | |||
|} | |||
Pseudohyperaldosteronism causes: | |||
{| class="wikitable" | |||
! rowspan="2" |Pseudohyperaldosteronism causes | |||
! rowspan="2" |Disease | |||
! rowspan="2" |Cause | |||
! | ! | ||
! colspan="3" |Labratory | |||
! | ! | ||
|- | |||
! | ! | ||
!Elevated mineralocorticoid | |||
!Renin | |||
!Aldosterone | |||
!Treatment | |||
|- | |- | ||
| | | rowspan="9" |Endogenous causes | ||
|Deficiency of 17a-hydroxylase | |||
| | |||
| | | | ||
| rowspan="2" |Deoxycorticosterone (DOC) | |||
| rowspan="2" |↓ | |||
| rowspan="2" |↓ | |||
| rowspan="2" | | |||
|- | |||
|11b-hydroxylase | |||
| | | | ||
| | | | ||
|- | |- | ||
| | |Apparent mineralocorticoid excess syndrome (AME) | ||
|Genetic or acquired defect of 11-HSD | |||
| | |||
| | |||
|↓ | |||
|↓ | |||
|dexamethasone and/or MR-blockers | |||
|- | |||
|Liddle’s syndrome | |||
|Mutation of the epithelial sodium channels (ENaC) gene in the distal renal tubules | |||
| | |||
| | |||
|↓ | |||
|↓ | |||
|amiloride or triamterene can reverse the clinical picture reactivating the renin aldosterone | |||
|- | |||
|Cushing’s syndrome | |||
|The main pathogenetic mechanism is linked to the excess | |||
of cortisol which saturates 11-HSD2 activity, allowing cortisol to bind MR. A similar picture is also related to over secretion of cortisol by adrenocortical carcinomas. In some cases the disease is associated with secondary hyperaldosteronism due to a direct activation of the renin angiotensin system by glucocorticoids. | |||
| | |||
| | |||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |Insensitivity to glucocorticoids (Chrousos syndrome) | ||
|mutations in glucocorticoid receptor (GR) gene | |||
| | |||
|Deoxycorticosterone (DOC) | |||
|↓ | |||
|↓ | |||
|dexamethasone | |||
|- | |||
|Aldosterone-secreting adrenocortical carcinoma | |||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |Geller’s syndrome | ||
|mutation of MR that alters its specificity and allows progesterone to bind MR | |||
|severe hypertension particularly during pregnancy | |||
| | | | ||
|↓ | |||
|↓ | |||
| | | | ||
|- | |||
|Gordon’s syndrome or pseudohypoaldosteronism type 2 | |||
|due to different mutations correlated to different phenotypes. Mutations of at least four genes have been identified, including WNK1 and WNK4 | |||
|hypertension, characterized by hyperkalemia, normal renal function | |||
| | | | ||
|↓ | |||
|↓ | |||
|thiazide diuretics and/or dietary sodium restriction | |||
|- | |- | ||
| | | rowspan="7" |Exogenous causes | ||
|Corticosteroids with mineralocorticoid activity | |||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |Hypersodic diets | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |Water intossications | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |Licorice | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|grapefruit | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Contraceptives | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Some progestins | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| rowspan="7" |Particular causes of hypertension | |||
|Sclerosis of juxtaglomerular apparatus (diabetic microangiopathy and/or of the elderly) | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|FANS | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|B-Adrenergic agonists | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Aging | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Low-renin essential hypertension | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Autonomic dysfunction | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Partial/total nephrectomy or removal of renal tissue | |||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
| | | | ||
|} | |} | ||
== Differentiating Diagnosis == | == Differentiating Diagnosis == |
Revision as of 18:02, 15 September 2017
https://https://www.youtube.com/watch?v=JBfkGNr01V8%7C350}} |
Hyperaldosteronism Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
This page contains general information about Hyperaldosteronism. For more information on specific types, please visit the pages on Primary hyperaldosteronism, and Secondary hyperaldosteronism.
Synonyms and keywords: Aldosteronism
Overview
Classification
Aldosteronism and mineralocorticoid excess may be classified into two types, primary hyperaldosteronism (conn's syndrome) and secondary hyperaldosteronism. The different types of aldosteronism described in the below table:
Cause | Laboratory | ||||
---|---|---|---|---|---|
Renin activity | Aldosterone levels | urinary free cortisone | |||
Renin-producing tumors | ↑ | ↑ | ↓ | ||
Apparent mineralocorticoid excess | ↓ | ↓ | ↓↓ | ||
Licorice ingestion | ↓ | ↓ | Moderate ↑ | ||
Ectopic ACTH production | ↓ | ↑ | Markedly ↑↑ | ||
Primary hyperaldosteronism | ↓ | ↑ | ↓ | ||
Familial hyperaldosteronism | ↓ | ↑ | ↓ | ||
Cushing syndrome | ↓ | ↑ | Markedly ↑↑ | ||
Renal artery stenosis | ↑ | ↑ | ↓ | ||
Liddle's syndrome | ↓ | ↓ | ↓ | ||
Diuretic use | Nl | ↓ | |||
17 alpha hydroxylase deficiency | ↓ | ↓ | ↓ | ||
11 beta hydroxylase deficiency | ↓ | ↓ | ↓ | ||
Coarctation of aorta | ↓ |
Pseudohyperaldosteronism causes:
Pseudohyperaldosteronism causes | Disease | Cause | Labratory | ||||
---|---|---|---|---|---|---|---|
Elevated mineralocorticoid | Renin | Aldosterone | Treatment | ||||
Endogenous causes | Deficiency of 17a-hydroxylase | Deoxycorticosterone (DOC) | ↓ | ↓ | |||
11b-hydroxylase | |||||||
Apparent mineralocorticoid excess syndrome (AME) | Genetic or acquired defect of 11-HSD | ↓ | ↓ | dexamethasone and/or MR-blockers | |||
Liddle’s syndrome | Mutation of the epithelial sodium channels (ENaC) gene in the distal renal tubules | ↓ | ↓ | amiloride or triamterene can reverse the clinical picture reactivating the renin aldosterone | |||
Cushing’s syndrome | The main pathogenetic mechanism is linked to the excess
of cortisol which saturates 11-HSD2 activity, allowing cortisol to bind MR. A similar picture is also related to over secretion of cortisol by adrenocortical carcinomas. In some cases the disease is associated with secondary hyperaldosteronism due to a direct activation of the renin angiotensin system by glucocorticoids. |
||||||
Insensitivity to glucocorticoids (Chrousos syndrome) | mutations in glucocorticoid receptor (GR) gene | Deoxycorticosterone (DOC) | ↓ | ↓ | dexamethasone | ||
Aldosterone-secreting adrenocortical carcinoma | |||||||
Geller’s syndrome | mutation of MR that alters its specificity and allows progesterone to bind MR | severe hypertension particularly during pregnancy | ↓ | ↓ | |||
Gordon’s syndrome or pseudohypoaldosteronism type 2 | due to different mutations correlated to different phenotypes. Mutations of at least four genes have been identified, including WNK1 and WNK4 | hypertension, characterized by hyperkalemia, normal renal function | ↓ | ↓ | thiazide diuretics and/or dietary sodium restriction | ||
Exogenous causes | Corticosteroids with mineralocorticoid activity | ||||||
Hypersodic diets | |||||||
Water intossications | |||||||
Licorice | |||||||
grapefruit | |||||||
Contraceptives | |||||||
Some progestins | |||||||
Particular causes of hypertension | Sclerosis of juxtaglomerular apparatus (diabetic microangiopathy and/or of the elderly) | ||||||
FANS | |||||||
B-Adrenergic agonists | |||||||
Aging | |||||||
Low-renin essential hypertension | |||||||
Autonomic dysfunction | |||||||
Partial/total nephrectomy or removal of renal tissue |
Differentiating Diagnosis
Hyperaldosteronism should be differentiated from other diseases causing hypertension and hypokalemia for example:
- Renal artery stenosis
- Cushing's syndrome
- Congenital adrenal hyperplasia (CAH)
- Liddle's syndrome
- Diuretic use
- Licorice ingestion
- Renin-secreting tumors
Hypertension and Hypokalemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Plasma renin activity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal or High (Plasma Renin/Aldosterone ratio <10 | Suppressed (Plasma Renin/Aldosterone ratio >20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Renin-secreting tumors *Diuretic use *Renovascular hypertension *Coarctation of aorta *Malignant phase hypertension | Urinary aldosterone | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Elevated | Normal | Low | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conn's syndrome (Primary aldosteronism) | Profound K+ depletion | • 17 alpha hydroxylase deficiency • 11 beta hydroxylase deficiency • Liddle's syndrome • Licorice ingestion • Deoxycortisone producing tumor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Add Mineralocrticoid antagonist for 8 weeks | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BP response | No BP response | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
• Deoxycorticosterone excess( Tumor, 17 alpha hydroxylase and 11 beta hydroxylase deficiency) • Licorice ingestion •Glucocorticoid resistance | Liddle's syndrome) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||